StockData
Legend Biotech Corp logo

Legend Biotech Corp (LEGN) stock

LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.25+0.14 (+0.87%)

Close on Nov 18, 2026Market cap $3.01BP/E –Yield –

Legend Biotech market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Legend Biotech's market cap was $3.66B on Nov 11, 2026, against $5.10B a year earlier. Over the last 5 years it ranged from $3.22B to $12.01B, with a median of $6.65B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.66B-8.6%
2025Dec 31, 2025$4.00B-32.6%
2024Dec 31, 2024$5.94B-42.6%
2023Dec 29, 2023$10.34B+47.1%
2022Dec 30, 2022$7.03B+27.7%
2021Dec 31, 2021$5.51B+95.6%
2020Dec 31, 2020$2.82B–

More Legend Biotech figures

See a number that looks wrong?